Gemphire shares crater after its LDL drug comes up short in PhIIb
Just two months after Gemphire $GEMP CEO Mina Sooch abruptly left the helm, the biotech is reporting out some disappointing new LDL data …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
